Suppr超能文献

采用热熔挤出技术制备的聚合物辅助阿立哌唑-己二酸共晶体

Polymer-Assisted Aripiprazole-Adipic Acid Cocrystals Produced by Hot Melt Extrusion Techniques.

作者信息

Butreddy Arun, Sarabu Sandeep, Bandari Suresh, Dumpa Nagireddy, Zhang Feng, Repka Michael A

机构信息

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.

College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.

出版信息

Cryst Growth Des. 2020 Jul;20(7):4335-4345. doi: 10.1021/acs.cgd.0c00020. Epub 2020 Jun 2.

Abstract

Pharmaceutical cocrystals are a promising strategy to increase the solubility and dissolution rate of poorly soluble drugs. However, their manufacturing process requires a large quantity of solvents. The present study aimed to produce cocrystals by a solvent-free hot melt extrusion (HME) method to improve their solubility and dissolution rate. Aripiprazole (ARP) and adipic acid (ADP) were used as a weakly basic drug and acidic coformer, respectively. The processability of a plain ARP-ADP physical mixture (PM) compared with a PM with 5% Soluplus® (SOL) was investigated. Incorporating 5% SOL into the ARP-ADP blend reduced the processing torque and improved processability. The effects of temperature and screw speed on the formation of cocrystals were studied, and cocrystals were characterized by differential scanning calorimetry (DSC), fourier transform infrared (FTIR) spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, powder X-ray diffraction (PXRD), scanning electron microscopy, and hot-stage microscopy. FTIR spectra revealed noncovalent interaction between ARP and ADP, which was confirmed by NMR spectra. Similarly, PXRD data exhibited characteristic peaks confirming the formation of new crystalline material. Further, the results indicated that cocrystals demonstrated higher dissolution rates and improved compressibility, as well as enhanced flow characteristics compared with pure ARP, suggesting its suitability in the development of solid dosage forms.

摘要

药物共晶体是提高难溶性药物溶解度和溶解速率的一种有前景的策略。然而,它们的制造过程需要大量溶剂。本研究旨在通过无溶剂热熔挤出(HME)方法制备共晶体,以提高其溶解度和溶解速率。分别使用阿立哌唑(ARP)和己二酸(ADP)作为弱碱性药物和酸性共形成物。研究了普通ARP-ADP物理混合物(PM)与含5% Soluplus®(SOL)的PM的可加工性。在ARP-ADP共混物中加入5% SOL可降低加工扭矩并提高可加工性。研究了温度和螺杆转速对共晶体形成的影响,并通过差示扫描量热法(DSC)、傅里叶变换红外(FTIR)光谱、核磁共振(NMR)光谱、粉末X射线衍射(PXRD)、扫描电子显微镜和热台显微镜对共晶体进行了表征。FTIR光谱揭示了ARP和ADP之间的非共价相互作用,NMR光谱证实了这一点。同样,PXRD数据显示出特征峰,证实了新晶体材料的形成。此外,结果表明,与纯ARP相比,共晶体表现出更高的溶解速率、更好的可压缩性以及增强的流动特性,表明其适用于固体剂型的开发。

相似文献

6
A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.一种新型可挤出的羟丙甲纤维素:AFFINISOL™ HPMC HME。
AAPS PharmSciTech. 2016 Feb;17(1):106-19. doi: 10.1208/s12249-015-0395-9. Epub 2015 Sep 4.

引用本文的文献

10
Recent Advances in Pharmaceutical Cocrystals: From Bench to Market.药用共晶体的最新进展:从实验室到市场
Front Pharmacol. 2021 Nov 11;12:780582. doi: 10.3389/fphar.2021.780582. eCollection 2021.

本文引用的文献

1
Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.阿托伐他汀钙共结晶对溶出度的增强作用
Adv Pharm Bull. 2019 Oct;9(4):559-570. doi: 10.15171/apb.2019.064. Epub 2019 Oct 24.
6
Succinic, fumaric, adipic and oxalic acid cocrystals of promethazine hydrochloride.盐酸异丙嗪的琥珀酸、富马酸、己二酸和草酸共晶体。
Acta Crystallogr C Struct Chem. 2019 Feb 1;75(Pt 2):107-119. doi: 10.1107/S2053229618017904. Epub 2019 Jan 16.
10
Continuous manufacturing of co-crystals: challenges and prospects.共晶连续制造:挑战与展望。
Drug Deliv Transl Res. 2018 Dec;8(6):1726-1739. doi: 10.1007/s13346-018-0479-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验